previous compound ID: 1341 next compound
InChIKey: MAEIEVLCKWDQJH-UHFFFAOYSA-N
SMILES: CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"GW Carlile" "B Kus" "SD Macknight" "D Rotin" "E Matthes" "J Liao" "DY Thomas" "R Robert" "JW Hanrahan" "J Goepp"

chemical graph of compound 1341





CID is 2471
synonyms found at PubChem are:
bumetanide, 28395-03-1, 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid, Bumex, Burinex, Fordiuran, Lunetoron, Fontego, Segurex, Bumetanida, Bumetanidum, Ro 10-6338, Aquazone, Bumethanide, Burine, Butinat, Cambiex, Diurama, Yurinex, Bumetanidum [INN-Latin], Bumetanida [INN-Spanish], Lixil-Leo, 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid, Lixil, PF 1593, Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-, Bufenox, UNII-0Y2S3XUQ5H, Bumex (TN), Bumetanide [USAN:BAN:INN:JAN], EINECS 249-004-6, PF-1593, BRN 2185351, 0Y2S3XUQ5H, MLS000028457, CHEBI:3213, Bumetanide (Ro 10-6338), BENZOIC ACID, 3-(BUTYLAMINO)-4-PHENOXY-5-SULFAMOYL-, C17H20N2O5S, MAEIEVLCKWDQJH-UHFFFAOYSA-N, 3-(butylamino)-4-phenoxy-5-sulfamoyl-benzoic acid, NCGC00015149-02, SMR000058418, CAS-28395-03-1, DSSTox_CID_2699, B 3023, 3-butylamino-4-phenoxy-5-sulfamoyl-benzoic acid, DSSTox_RID_76695, 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid, DSSTox_GSID_22699, 3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid, Bumedyl, Drenural, Miccil, SR-01000003062, Bumetanide (JP15/USP), Bumex, Bumetanide, Prestwick_679, PF1593, Bumetanide Leo Brand, Bumetanide [USAN:USP:INN:BAN:JAN], Bumetanide Roche Brand, Spectrum_001317, Bumetanide, >=98%, Leo Brand of Bumetanide, Bumetanide Atlantis Brand, Opera_ID_1734, Prestwick0_000276, Prestwick1_000276, Prestwick2_000276, Prestwick3_000276, Spectrum2_001050, Spectrum3_001481, Spectrum4_000030, Spectrum5_001212, Lopac-B-3023, Roche Brand of Bumetanide, Bumetanide Farmacusi Brand, Bumetanide Grossmann Brand, Bumetanide Senosiain Brand, D0R7HO, AC1L1DR5, cid_2471, Bumetanide AstraZeneca Brand, Atlantis Brand of Bumetanide, CHEMBL1072, Lopac0_000162, SCHEMBL27525, BSPBio_000152, BSPBio_001508, BSPBio_003061, KBioGR_000228, KBioGR_000439, KBioSS_000228, KBioSS_001797, Farmacusi Brand of Bumetanide, Grossmann Brand of Bumetanide, MLS001148265, Senosiain Brand of Bumetanide, DivK1c_000034, SPECTRUM1502004, SPBio_000980, SPBio_002371, AstraZeneca Brand of Bumetanide, BPBio1_000168, Bumetanide (JP15/USP/INN), Bumetanide (JP17/USP/INN), GTPL4837, DTXSID5022699, BDBM25903, CTK8B4560, HMS500B16, KBio1_000034, KBio2_000228, KBio2_001797, KBio2_002796, KBio2_004365, KBio2_005364, KBio2_006933, KBio3_000455, KBio3_000456, KBio3_002561, MolPort-003-666-390, NINDS_000034, Bio1_000421, Bio1_000910, Bio1_001399, Bio2_000228, Bio2_000708, HMS1361L10, HMS1568H14, HMS1791L10, HMS1921B20, HMS1989L10, HMS2089P13, HMS2092N03, HMS2095H14, HMS2230P15, HMS3259O08, HMS3260B05, HMS3374E02, HMS3402L10, HMS3654B13, HMS3712H14, Pharmakon1600-01502004, KS-00000XN2, ZINC3813061, Tox21_110088, Tox21_500162, ANW-45473, CCG-40125, MFCD00078949, NSC758145, s1287, AKOS015896600, Tox21_110088_1, AC-8115, AN-8345, CS-1821, DB00887, KS-5211, LP00162, MCULE-6802013568, NC00550, NE48825, NSC-758145, Ro-106338, IDI1_000034, IDI1_033978, SMP1_000049, NCGC00015149-01, NCGC00015149-03, NCGC00015149-04, NCGC00015149-05, NCGC00015149-06, NCGC00015149-07, NCGC00015149-08, NCGC00015149-09, NCGC00015149-10, NCGC00015149-11, NCGC00015149-12, NCGC00015149-13, NCGC00015149-15, NCGC00015149-16, NCGC00022072-03, NCGC00022072-04, NCGC00022072-05, NCGC00022072-06, NCGC00022072-07, NCGC00022072-08, NCGC00260847-01, Ro-10-6338, AJ-45693, BC208864, CPD000058418, HY-17468, KB-48483, LS-36330, SAM002564195, SC-12128, SBI-0050150.P003, AB0012138, AB2000031, ST2404803, TC-134218, AB00052253, EU-0100162, FT-0623285, ST51014910, 3-butylamino-4-phenoxy-5-sulfamoylbenzoic acid, D00247, J10080, 28395-03-1,28434-74-4(sodiumsalt), 3-butylamino-4-phenoxy-5-sulphamyl-benzoic acid, AB00052253-15, AB00052253-16, AB00052253_17, AB00052253_18, 3-n-butylamino-4-phenoxy-5-sulfamyl-benzoic acid, 3-n-butylamino-4-phenoxy-5-sulphamyl-benzoic acid, 395B031, A819434, I06-2277, J-017055, SR-01000003062-2, SR-01000003062-4, SR-01000003062-7, BRD-K38197229-001-06-7, BRD-K38197229-001-17-4, Z1550648769, Bumetanide, British Pharmacopoeia (BP) Reference Standard, Bumetanide, European Pharmacopoeia (EP) Reference Standard, Bumetanide, United States Pharmacopeia (USP) Reference Standard